Yunlan Fang
About Yunlan Fang
Yunlan Fang is a Senior Scientist in DMPK at Bristol Myers Squibb with extensive experience in pharmacometrics and toxicokinetics.
Current Position at Bristol Myers Squibb
Yunlan Fang is currently employed as a Senior Scientist in Drug Metabolism and Pharmacokinetics (DMPK) at Bristol Myers Squibb. In this role, they focus on studying the absorption, distribution, metabolism, and excretion (ADME) of drug candidates to optimize their therapeutic efficacy and safety profiles.
Previous Experience at Corteva Agriscience
From 2019 to 2021, Yunlan Fang served as a Research Toxicologist specializing in Metabolism and Toxicokinetics at Corteva Agriscience. During their tenure, they were involved in examining the metabolic pathways and toxicological impacts of agricultural chemicals, contributing to the development of safer and more effective products.
Work at WuXi AppTec
Yunlan Fang has significant experience at WuXi AppTec, spanning two distinct roles over four years. From 2017 to 2019, they worked as a Research Scientist in the Laboratory Testing Division at the New Jersey site. Prior to that, they served as a Postdoctoral Research Associate at the same facility from 2015 to 2017. During this period, they made important contributions to laboratory testing and research in pharmacometrics and toxicokinetics.
Educational Background
Yunlan Fang holds a Doctor of Philosophy (PhD) in Chemical and Biomolecular Engineering from Tulane University, obtained between 2009 and 2015. Additionally, they completed a Master's degree in Pharmacometrics at the University of Maryland, Baltimore (UMB) from 2019 to 2022. Their academic training has equipped them with a comprehensive understanding of chemical engineering and quantitative pharmacology.
Research Publications and Conference Presentations
Yunlan Fang has authored several peer-reviewed publications in the fields of pharmacometrics and toxicokinetics. Furthermore, they have presented their research findings at international conferences, including those organized by the American Society for Clinical Pharmacology and Therapeutics (ASCPT). These accomplishments reflect their active engagement with the scientific community.
Research Grant from NIH
Yunlan Fang received a research grant from the National Institutes of Health (NIH) for their work on drug metabolism and pharmacokinetics. This funding supported their significant contributions to understanding the metabolism and disposition of pharmaceutical compounds, which are critical for drug development.
Mentorship and Innovation at WuXi AppTec
While at WuXi AppTec, Yunlan Fang mentored graduate students and postdoctoral researchers, providing guidance and support to emerging scientists. Additionally, they developed a novel analytical method for quantifying drug metabolites, which has been widely adopted by research laboratories, demonstrating their innovation and influence in the field.